mRNA

Das Mainzer Unternehmen hat nach dem Weggang seiner Gründer eine erste strategische Entscheidung getroffen und bleibt bei der mrna-Technologie.

28. Oktober 2025 Von KI berichtet Fakten geprüft

A large retrospective study from the University of Florida and The University of Texas MD Anderson Cancer Center, published in Nature, reports that patients with advanced non-small cell lung cancer or metastatic melanoma lived significantly longer if they received a Pfizer-BioNTech or Moderna COVID-19 mRNA shot within 100 days of starting immune checkpoint inhibitors. The authors stress the findings are observational and will require confirmation in randomized trials.